Infection Control Market, By Types (Consumable, Equipment, and Services), By End Use (Hospitals, Clinical Laboratories, Healthcare Industries and Others) And Geography (North America, Europe, Asia Pacific, And Rest Of The World) – Analysis, Share, Trends, Size, & Forecast From 2014 – 2025

  • Product Code:
    RP-ID-10293987
  • Published Date:
    12 Jan 2021
  • Region:
    Global
  • Pages:
    110
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-48

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

REPORT HIGHLIGHT

The infection control market is estimated to represent a global market of USD 148.3 billion by 2017 with growth rate of 7.3%.

Market Dynamics

Infection control is associated with the products and technologies that are used to prevent healthcare-associated infections (HAI). HAI is one of the most common complications in clinics and hospital facilities. As per the estimates of the Agency for Healthcare Research and Quality, HAI result more than 1.7 million infections in different healthcare facilities that led to around 99,000 death yearly. Furthermore, the HAI added financial burden of USD 28.0 to USD 33.0 billion every year globally. Numerous government or non-government organizations have started to support projects on HAI preventions owing to the fact that financial burden and number of facilities affected by healthcare infections is increasing continuously. For example, the Agency for Healthcare Research and Quality (AHRQ) implemented the Comprehensive Unit-based Safety Program (CUSP). The program is based on the intensive care unit safety reporting system to address various healthcare-associated infections. These types of initiatives would, in turn, provide a healthy platform for the market development, leading to driving the market growth.

Types Takeaway

Infection control market is categorized as Consumable, Equipment, and Services. Consumables are world’s largest infection control market, capturing approximately 75% share of the market. A substantial share of this segment is attained by the wide usage of these products in different infection control procedures. Consumables segment is categorized as Personal protective equipment (PPE), Disinfectants, Sterilization consumables and Safety enhanced medical devices. In 2016, PPE reached a record high of 15.7 billion and is projected to dominate the market over the forecast period. This equipment includes face shields, respirators, medical gloves, and surgical gowns that provides protection against disease-causing organisms.

Disinfectors and Sterilization Equipment is categorized under equipment. Disinfectors are further divided as Washer, Flusher, and Endoscope Reprocessors. Sterilization equipment is categorized as Heat sterilization equipment, Low-temperature sterilization equipment, Liquid sterilization equipment and Radiation sterilization equipment. Services are divided into Contract sterilization (Eto, E-beam, and gamma sterilization) and Waste disposal. The end-user segment is viewed as Hospitals, Clinical Laboratories, Healthcare Industries and Others. Hospitals and healthcare industries, both led the global market, with each having more than 30% share.

Regional Takeaway

Regionally, North America (especially the U.S. market) hold the first spot in the global infection control market. Increasing demand for infection control products owing to the continuous rise in HAI-related problems drives the market growth. According to the Centers for Disease Control and Prevention (CDC), around 250,000 cases of central line-associated bloodstream infections (CLABSIs) occur in the U.S. hospitals every year. Also, CDC stated that approximately 30,000 to 60,000 patients die every year due to the CLABSIs. Asia Pacific region exhibits fastest growth over the forecast period.

Favorable government initiatives are considered to be the primary driving factor for the market growth. Regulatory policies enforced by healthcare organizations in India and China are favoring higher biosafety to improve the quality of healthcare infrastructure. Organizations such as Asia‐Pacific Biosafety Association trains concerned professionals in the region for biosafety principles and practices. Such parameters will boost the growth of the infection control market in coming years.

Key Vendor Takeaway

Companies such as Getinge Group, Belimed AG, 3M Company, Halyard Health, Inc., and Advanced Sterilization Products are operating in this market. These companies are actively engaged in research and development activities to expand their presence in infection control segment. Due to this, many companies have posted significant revenue from infection control products. For example, as per our estimates, Getinge Group recorded more than USD 700 million from their infection control product sale. Introduction of new products has helped companies to record significant revenue share. For instance, in July 2016, 3M Company introduced biological indicator, featured with four-hour rapid readout for vaporized hydrogen peroxide sterilization. The product is designed to provide results in 4 hours and monitored steam sterilization loads effectively.

The market size and forecast for each segment has been provided for the period 2014 to 2025, considering 2015 as the base year. The report also provides the compounded annual growth rate (% CAGR) for the forecast period 2016 to 2025 for every reported segment.

The years considered for the study are:

Historical Year – 2014 & 2015
Base Year – 2015
Estimated Year – 2016
Projected Year – 2025
TARGET AUDIENCE

Traders, Distributors, And Suppliers
Manufacturers
Hospitals
Government and Regional Agencies and Research Organizations
Consultants
Distributors
SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

MARKET, BY TYPES

Consumables
Equipment
Services
MARKET, BY APPLICATION

Hospitals
Clinical Laboratories
Healthcare Industries
Others
MARKET, BY REGION

North America
U.S.
Canada
Europe
Germany
France
Rest of Europe
Asia Pacific
India
China
Rest of APAC
Rest of the World
Middle East and Africa
Latin America

TABLE OF CONTENT
1. INFECTION CONTROL MARKET OVERVIEW
1.1. Study Scope
1.2. Base Year
1.3. Assumption and Methodology
2. EXECUTIVE SUMMARY
2.1. Key Market Facts
2.2. Geographical Scenario
2.3. Companies in the Market
3. INFECTION CONTROL KEY MARKET TRENDS
3.1. Market Drivers
3.1.1. Impact Analysis of Market Drivers
3.2. Market Restraints
3.2.1. Impact Analysis of Market Restraints
3.3. Market Opportunities
3.4. Market Future Trends
4. INFECTION CONTROL INDUSTRY STUDY
4.1. Company Activity Analysis
4.2. Regulatory Framework Analysis
4.3. Market Attractiveness Analysis
4.4. Value Chain Analysis
5. INFECTION CONTROL MARKET LANDSCAPE
5.1. Market Share Analysis
5.2. Key Innovators
6. INFECTION CONTROL MARKET – BY TYPES:
6.1. Overview
6.2. Nucleic Acid Aptamers
6.2.1. Overview
6.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
6.3. Peptide Aptamers
6.3.1. Overview
6.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7. INFECTION CONTROL MARKET – BY APPLICATION:
7.1. Overview
7.2. Therapeutics
7.2.1. Overview
7.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.3. Diagnostics
7.3.1. Overview
7.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.4. Research and Development
7.4.1. Overview
7.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
7.5. Others
7.5.1. Overview
7.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8. INFECTION CONTROL MARKET– BY GEOGRAPHY
8.1. Introduction
8.2. North America
8.2.1. Overview
8.2.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.3. U.S.
8.2.3.1. Overview
8.2.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.2.4. Canada
8.2.4.1. Overview
8.2.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3. Europe
8.3.1. Overview
8.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.3. France
8.3.3.1. Overview
8.3.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.4. Germany
8.3.4.1. Overview
8.3.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.3.5. Rest of Europe
8.3.5.1. Overview
8.3.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4. Asia Pacific (APAC)
8.4.1. Overview
8.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.3. China
8.4.3.1. Overview
8.4.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.4. India
8.4.4.1. Overview
8.4.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.4.5. Rest of APAC
8.4.5.1. Overview
8.4.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5. Rest of the World
8.5.1. Overview
8.5.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.3. Latin America
8.5.3.1. Overview
8.5.3.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
8.5.4. Middle East and Africa
8.5.4.1. Overview
8.5.4.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2014 – 2025, (US$ Million)
9. KEY VENDOR ANALYSIS
9.1. Opthotech Corporation
9.1.1. Company Overview
9.1.2. SWOT Analysis
9.1.3. Key Developments
9.2. Somalogic, Inc.
9.2.1. Company Overview
9.2.2. SWOT Analysis
9.2.3. Key Developments
9.3. Aptagen
9.3.1. Company Overview
9.3.2. SWOT Analysis
9.3.3. Key Developments
9.4. Aptamer Group
9.4.1. Company Overview
9.4.2. SWOT Analysis
9.4.3. Key Developments
9.5. NOXXON Pharma
9.5.1. Company Overview
9.5.2. SWOT Analysis
9.5.3. Key Developments
10. 360 DEGREE ANALYSTVIEW
11. APPENDIX
11.1. Research Methodology
11.2. Abbreviations
11.3. Disclaimer
11.4. Contact Us

Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports